The pathophysiology of hypoactive sexual desire disorder in women

  title={The pathophysiology of hypoactive sexual desire disorder in women},
  author={Anita H. Clayton},
  journal={International Journal of Gynecology \& Obstetrics},
  • A. Clayton
  • Published 1 July 2010
  • Psychology
  • International Journal of Gynecology & Obstetrics

Hypoactive Sexual Desire Disorder and Current Pharmacotherapeutic Options in Women

The Decreased Sexual Desire Screener is a shortened diagnostic method designed to help doctors who are not specialized in female sexual dysfunction to diagnose acquired HSDD in women.

Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.

High prevalence and negative impact on the overall health and well-being of women, primary care health professionals and women's health practitioners need to be actively aware of HSDD, particularly because patients may be reluctant or unwilling to initiate a discussion about their sexual concerns during routine visits.

Bremelanotide for Treatment of Female Hypoactive Sexual Desire

Bremelanotide is a promising way to treat HSDD and showed improvements in desire, arousal, and orgasm scores when 1.75 mg of bremelanotide was administered before sexual activity compared to a placebo.

Testosterone Supplementation for Hypoactive Sexual Desire Disorder in Women

Although studies have shown some benefit with testosterone supplementation in women with HSDD, conflicting evidence and debate regarding the clinical efficacy of testosterone remain.

Prevalence of Diminished Libido and Hypoactive Sexual Desire Disorder

Low sexual desire (LSD) is a rather common sexological symptom, which occurs in 33.4% of women, taking the first place among other such symptoms, and in 15.8% of men. At the same time, hypoactive

Hypoactive sexual desire disorder (HSDD) is not “female erectile dysfunction (ED)”: challenges with the characterization of HSDD in women based on a systematic literature review

HSDD and ED are distinct conditions affecting different phases of the sexual response model, and thus require clear and unique clinical characterization and adequate communication between the health care professional and patient for appropriate diagnosis, management and treatment.

The sexual dysfunction in females with type 1 diabetes: Still an underestimated issue?

The sexual difficulties among T1DM women require much more attention and their regular annual in-depth evaluation should routinely include queries regarding the presence of depressive symptoms and their sexual functioning.

The Effectiveness of Systemic Sex Therapy on Sexual Desire Improvement in Women With Hypoactive Sexual Desire Disorder(HSDD)

Introduction: Hypoactive sexual desire disorder is one of the most common sexual dysfunctions in women, associated with the persistent or recurrent deficiency and/or absence of sexual

Evaluation and Management of Hypoactive Sexual Desire Disorder




Epidemiology and neurobiology of female sexual dysfunction.

  • A. Clayton
  • Psychology, Medicine
    The journal of sexual medicine
  • 2007
Understanding of the contributions of the CNS neuroendocrine and neurotransmitter systems that modulate sexual behavior is improving, and central nervous system (CNS) control of the sexual response is a relatively new area of scientific exploration.

Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.

Sexual desire scores and sexual arousal, orgasm, and sexual pleasure were highly correlated, demonstrating that low sexual desire is frequently associated with decreased functioning in other aspects of sexual response.

Female Sexual Response: The Role of Drugs in the Management of Sexual Dysfunction

  • R. Basson
  • Psychology
    Obstetrics and gynecology
  • 2001

Relationship between hypoactive sexual desire disorder and aging.

Sexual sequelae of general medical disorders

Recent advances in women’s sexual function and dysfunction

Understanding of the pathophysiology of chronic pain can be applied to the chronic intermittent pain and allodynia of chronic dyspareunia and mental well-being and other psychological and biological factors modulating desire, arousability, and response are areas of active research.

Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)

HSDD is prevalent among women at all reproductive stages, with younger surgically postmenopausal women at greater risk, and is associated with a less active sex life and decreased sexual and relationship satisfaction.

Sexual dysfunction in the United States: prevalence and predictors.

The results indicate that sexual dysfunction is an important public health concern, and emotional problems likely contribute to the experience of these problems.

Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study.

There is an opportunity to improve patient care and life satisfaction by offering physicians training on diagnosis and management of hypoactive sexual desire disorder (HSDD) in the primary care setting.

Drugs of abuse and sexual functioning.

The relation between drugs of abuse and sexuality in three domains is explored: drugs and sexual dysfunctions, drugs and risky sexual behavior and drugs used as sexual aids.